Debate-2021

17:00 - 17:20

Vijayakumar G

Why is Insulin still a taboo and what can we do about it?

17:20 - 17:40

Bipin Sethi

The future of Insulin - What is in store?

17:40 - 17:50

Discussion

17:55 - 18:15

Manoj Chadha

The Bone and its metabolism in Diabetes and the lessons for the clinician

18:15 - 18:35

Sruti Chandrasekaran

Diabetes menstrual health and fertility and menopause: Implications for clinical care

18:35 - 18:45

Discussion

19:00 - 19:20

Sridhar S

Dapagliflozin: A single point cardio renal solution for diabetes

19:20 - 19:40

Karthik Balachandran

UK CPRD study results and clinical implications

19:40 - 20:00

Discussion

17:55 - 18:00

Sanjay Agarwal

Context Setting

18:00 - 18:15

Prasanna Kumar K M

Current evidence - Diabetes and Thyroid

18:15 - 18:25

Krishna G Seshadri

RSSDI Guidelines on Thyroid and T2DM

18:25 - 18:35

Vijaya Bhaskar Reddy

RSSDI Guidelines on Thyroid and T1DM

18:35 - 18:55

Panel Discussion

19:00 - 19:25Virtual

Unnikrishnan A G

Does Diabetes accelerate aging?

19:25 - 19:55Virtual

Mohan V

Making Excellence a habit

19:55 - 20:20Virtual

Dale Abel

Translational Medicine: Diabetes and Heart Failure - Pathophysiology and Therapeutic opportunities

20:20 - 20:45Virtual

Sunder Mudaliar

Fuel energetics and retinopathy

10:00 - 11:20

Tejal Lathia, Chitra Selvan

Mind your language - Workshop on communicating with patients - in person and digital

11:30 - 12:50

Sanjay Reddy, Rajiv Kovil, A K Das

Digital devices and technology to enhance your clinical practice - What, When and How?

13:45 - 14:00

Homage to a lost generation, National and State Anthem

14:00 - 14:10

Selvapandian P

Management of insomnia in the diabetic patient

14:10 - 14:20

Mohan K

Dry skin in diabetes - What works

14:20 - 14:30

Rajesh R P

Adhesive capsulitis

14:30 - 14:45

Discussion

14:50 - 15:10

Vijaya Bhaskar Reddy

Thin young adult with weight loss and new onset diabetes

15:10 - 15:30

Rajesh Rajput

34 year old IT shift worker with new onset diabetes

15:30 - 15:50

Suresh Damodaran

New onset diabetes in patient with a BMI > 35

15:50 - 16:00

Discussion

16:00 - 16:20

Karthik Balachandran

How have insulins suiting the Indian realities evolved over the century?

16:20 - 16:40

Sruti Chandrasekaran

Nuances in use of GLP1RA

16:40 - 16:55

Panel - Today and Beyond

17:15 - 17:30

Organising Committee

PRIMER Honors: Murthy S and Narasimhan M

17:30 - 18:15

Ramasubramanian V

Influenza and diabetes - Vicious Circle

18:15 - 18:40

Prasanna Kumar K M

Inflammation and Diabetes: The link

18:40 - 19:00

Suresh Damodaran

Unique Challenges of Diabetes Management in India: Postprandial Hyperglycemia and Glycemic Variability

10:00 - 11:20

Manoj Chawla, Usha Ayyagari

Choosing and interpreting glucose monitoring from SMBG to FGM

11:30 - 12:50

Manoj Chadha, Bipin Sethi

Choosing the right patient for an SGLT2i

13:45 - 14:00

Homage to a lost generation, National and State Anthem

14:00 - 14:05

J Damodaran

Context

14:05 - 14:15

Rama Mohan

Absolutely

14:15 - 14:25

Purvi Chawla

Certainly not

14:25 - 14:35

Audience Interaction

Rebuttal

14:35 - 14:40

J Damodaran

Balance view and Summary

14:50 - 15:10

Anjana Mohan

Diabetes in Women - the Indian story

15:10 - 15:30

Aravind S R

A reappraisal of the metabolic syndrome and its implications for clinical care

15:30 - 15:50

Shashank R Joshi

Diabesity and metabolic flexibility - The untold story

15:50 - 16:00

Discussion

16:00 - 16:20 Virtual

Unnikrishnan A G

Beta cell preservation

16:20 - 16:40 Virtual

Nagendra Boopathy

Estimating the lifetime benefits of treatment for heart failure

16:40 - 17:00 Virtual

Panel Discussion

17:15 - 17:30

Organising Committee

PRIMER Honors: Murthy S and Narasimhan M

17:30 - 17:50 Virtual

Banshi Saboo

Changing Perspectives in Type 1 Diabetes Management

17:55 - 18:15 Virtual

Susan Mandel

Thyroid Nodules

18:15 - 18:35 Virtual

Heiko Lickert

Inceptor counteracts insulin signaling in beta cells to regulate glycemia

18:35 - 18:55 Virtual

Rohit N. Kulkarni

Therapeutic implications of insulin action in the beta cell for diabetes

18:55 - 19:15 Virtual

Discussion

19:15 - 19:55 Virtual

Venkat Narayan K M

The origins of diabetes in Indians

20:00 - 20:45 Virtual

Ajit Varki

Distinctly Human Evolution of Sialic acid Biology: implications for "Uniquely Human" Diseases

08:45 - 10:00

Bharath Ramji, Muthukumaran Jayapaul

Testing and interpreting thyroid function and managing hypothyroidism - A case based workshop

10:05 - 10:25

Abraham Oomman

The Cardiology perspective

10:25 - 10:45

Discussion

10:45 - 10:55

Discussion

11:05 - 11:30

Shashank R Joshi

The impact of stress on diabetes and metabolic syndrome: An evidence based review

11:30 - 11:50

Manoj Chawla

Getting the most out of Gliptins in Indian patients

11:50 - 12:10

Vijaya Bhaskar Reddy

Towards clinical JUNCTION-DPP4 inhibitors

12:10 - 12:30

Discussion

12:30 - 12:50

Rajesh Rajput

Multifactorial approach to T2DM

12:50 - 13:00

Shashank R Joshi

Insulin @ 100: Evolution from Iletin to Humalog and beyond

13:00 - 13:30

Manoj Chawla, Usha Ayyagari, Vijaya Bhaskar Reddy, Rajesh Rajput

Panel Discussion

08:45 - 10:05

Muruganathan A, Balamurugan R, Rajiv Kovil

Difficult to control hypertension

10:05 - 10:25

Kumaravel Velayutham

Drug induced endocrinopathies

10:25 - 10:45

Karthik Balachandran

Labomas in Endocrinology

10:45 - 10:55

Discussion

11:00 - 11:30

Muthukumaran Jayapaul

Hyperthyroid drugs how much and how long?

11:30 - 11:50

Vijayakumar G

Time-in-range: Clinical Implications and Role of Gen 2.0 Basals

11:50 - 12:10

Muthukumaran Jayapaul

Evolution of Basal Insulin Optimization Approaches over 2 Decades in India

12:10 - 12:25

Discussion

12:30 - 12:45

Rajiv Kovil

Role of DPP4I (Focus on Linagliptin)

12:45 - 13:00

Suresh Damodaran

Role of SGLT2i - MF FDC

13:00 - 13:15

Krishna G Seshadri

Role of SLGT2i DPP4i FDC

13:15 - 13:30

Vijayakumar G

Empowering Cardio-Renal-Metabolic Outcomes in T2DM: Foundational Place of SGLT2-inhibition